{
  "bio": [
    "Leonard Schleifer cofounded drugmaker Regeneron in 1988, and remains CEO of the Tarrytown, New York company.",
    "Schleifer took Regeneron public in 1991; he owns nearly 4% of the company's common stock.",
    "Sales of Regeneron's blockbuster drug Eylea, a treatment for macular degeneration, reached $4 billion in the U.S. in 2018.",
    "Regeneron has developed six FDA-approved medicines.",
    "Schleifer attended Cornell on scholarship and dreamed of a medical career."
  ],
  "about": [
    "The son of a sweater manufacturer, Schleifer grew up in Queens, New York."
  ]
}